Advances in Clinical Toxicology (ACT)

ISSN: 2577-4328

Short Communication

Malaria Tests-DNA PCR and Quantitative Buffy Coat (QBC)

Authors: Waje T

DOI: 10.23880/act-16000232

Abstract

Malaria, considered a tropical disease, poses a significant threat to public health especially in Sub-Saharan Africa [1]. It is a blood borne disease caused by a protozoan parasite called plasmodium [1,2]. Being blood borne, the malaria parasite (Plasmodium) can be found in the blood of infected persons with possible transmission to others either through blood transfusion or vector bite [2]. The malaria vector is the female anopheles’ mosquito which bites an infected person, picks the plasmodium and transmits it on bite of another individual. Many measures are adopted all over the world to control malaria. Notable among others include: 

• Treatment of infected cases with drugs such as any of: Chloroquine phosphate (Most preferred), primaquine phosphate, atovaquone-proguanil (Malarone), Quinine sulfate (Qualaquine) with deoxycycline or the use of Artemisinin-based combination therapies (ACTs) (e.g., combination of artemether-lumefantrine (coartem) and artesunate-mefloquineuse.
• Use of some plants and plant parts as remedies.

Keywords:

View PDF

F1 europub scilit.net

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?